Categories AlphaGraphs, Earnings, Health Care
ABBV Infographic: AbbVie’s Q3 earnings beat estimates; revenue up 3%
Pharmaceutical company AbbVie, Inc. (NYSE: ABBV) reported a sharp increase in third-quarter adjusted earnings. The bottom line topped expectations, while revenues missed. The company also provided guidance for fiscal 2022.
Total revenues increased 3.3% year-over-year to $14.81 billion, aided by a strong performance by the immunology and neuroscience segments. But the top line missed the Street view.
At $3.66 per share, adjusted net income was sharply higher than the $2.83 per share profit reported in the prior-year period, and above the consensus forecast. Third-quarter unadjusted profit increased to $3.95 billion or $2.21 per share from $3.18 billion or $1.78 per share in the third quarter of 2021.
Check this space to read management/analysts’ comments on AbbVie’s Q3 2022 earnings
“We continue to see strong momentum from our key immunology assets, Skyrizi and Rinvoq, and this performance – combined with strength from other growth drivers within our diverse portfolio – has mitigated the impact of temporary economic headwinds on our aesthetics products to deliver another quarter of strong results,” said Richard A. Gonzalez, CEO of AbbVie.
Prior Performance
Most Popular
What to look for when Hormel Foods (HRL) reports Q4 2023 earnings
Shares of Hormel Foods Corporation (NYSE: HRL) were down over 1% on Monday. The stock has dropped 29% year-to-date. The food company is set to report its fourth quarter 2023 earnings
Kroger set to report Q3 results. Here’s everything you need to know
The Kroger Co. (NYSE: KR), a leading grocery retailer that operates both in-store and online, will be reporting earnings this week. The company, which is preparing to acquire rival retailer
Earnings Preview: Salesforce will likely deliver another strong quarter
Salesforce, Inc. (NYSE: CRM) achieved accelerated sales growth and profitability in recent quarters, in line with its transformation goal. The customer relationship management platform bets on new opportunities in generative